BridgeMD
Compares treatment options for Gastric Cancer
Official title OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
ClinicalTrials.gov ID: NCT05450835
What this study is testing
- What it's testing
- Abstract Background Our previous studies have shown OGT method significantly simplified overlap esophagojejunostomy with good short-term outcomes, and provided new perspectives for optimizing esophagojejunostomy. However, the safety and efficiency of OGT method still need evidence of randomized controlled trial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Aged 18-75 years;
- Primary lesion is pathologically diagnosed as gastric adenocarcinoma;
- Expected to live more than 1 year;
- Tumor located located in gastroesophageal junction (GEJ) involve esophagus no more than 2cm, or in the upper, upper to middle, or entire stomach, and...
- No history of upper abdominal surgery (except for laparoscopic cholecystectomy);
You likely can't join if
- Women during pregnancy or breast-feeding;
- Body temperature ≥ 38 °C before surgery or infectious disease with a systemic therapy indicated;
- Severe mental disease;
- Confirmed stage IV (AJCC 8th) during surgery
- Severe respiratory disease;
- Severe hepatic and renal dysfunction;
See the full eligibility criteria
- Aged 18-75 years;
- Primary lesion is pathologically diagnosed as gastric adenocarcinoma;
- Expected to live more than 1 year;
- Tumor located located in gastroesophageal junction (GEJ) involve esophagus no more than 2cm, or in the upper, upper to middle, or entire stomach, and intend to perform laparoscopic total gastrectomy with D2...
- No history of upper abdominal surgery (except for laparoscopic cholecystectomy);
- Preoperative performance status (ECOG, Eastern Cooperative Oncology Group) of 0 or 1;
- Preoperative ASA (American Society of Anesthesiologists) scoring: I-III;
- Without preoperative radiotherapy;
- Did not found metastasis preoperatively and intraoperatively;
- Sufficient organ functions;
- Written informed consent.
- Women during pregnancy or breast-feeding;
- Body temperature ≥ 38 °C before surgery or infectious disease with a systemic therapy indicated;
- Severe mental disease;
- Confirmed stage IV (AJCC 8th) during surgery
- Severe respiratory disease;
- Severe hepatic and renal dysfunction;
- Unstable angina pectoris or history of myocardial infarction within 6 months;
- History of cerebral infarction or cerebral hemorrhage within 6 months;
- Gastric cancer complications (bleeding, perforation, obstruction) that requiring emergency surgery;
- Performing hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Quanzhou, Fujian, China
- Guangzhou, Guangdong, China
- Shantou, Guangdong, China
- Ganzhou, Guangxi, China
- Changsha, Hunan, China
- Hengyang, Hunan, China
- Changchun, Jilin, China
- Shenyang, Liaoning, China
- Changzhi, Shanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Quanzhou, Fujian, China; Guangzhou, Guangdong, China; Shantou, Guangdong, China; Ganzhou, Guangxi, China; Changsha, Hunan, China; Hengyang, Hunan, China and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.